Skip to main content

Test Price

450 AED

✅ Home Collection Available

Mycoplasma Pneumoniae IgM Serum Test in UAE | 450 AED | DHA-Licensed Laboratory

Executive Summary & Core Metrics

Diagnostic Accuracy Guarantee: 99.9% clinical sensitivity achieved through ISO 9001:2015 accredited, quantitative ELISA protocols. Your serology results are definitive and actionable.
VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection: Hospital-grade specimen collection available daily from 8 AM to 11 PM. ISO-certified cold-chain logistics preserve sample integrity from your residence to our DHA-licensed laboratory.
Expert Post-Test Guidance: Complimentary telephonic consultation by a DHA-registered General Practitioner to interpret your IgM serology within your full clinical context.
Instant Insurance Verification: Direct billing confirmation via WhatsApp. Forward your policy document to +971 54 548 8731 for a response within 60 seconds.

Test Overview & Methodology

The Mycoplasma Pneumoniae IgM Serum Test delivers a definitive serological snapshot of an active or very recent atypical pneumonia infection, enabling clinicians to distinguish Mycoplasma pneumoniae from viral or other bacterial etiologies. This quantitative ELISA assay detects IgM antibodies produced during the acute phase of infection, providing critical evidence to initiate targeted macrolide therapy without delay. Within the UAE's respiratory care framework, its rapid turnaround and high specificity offer a decisive advantage in guiding guideline-directed antibiotic stewardship.

Testing Parameter Our Test (DHA Standard) Closest Alternative
Target & Phase IgM Antibodies (Acute Phase) IgG Antibodies (Convalescent / Past Infection)
Methodology Quantitative ELISA (ISO 9001:2015) Qualitative Rapid Card Test
Diagnostic Window 3 to 7 days post-symptom onset 2 or more weeks post-infection
Clinical Utility Guides immediate macrolide therapy Confirms retrospective exposure
Turnaround Time Next-Day Report 3 to 5 Days

Physician Insight & Safety Protocols

"A positive Mycoplasma IgM result provides a critical serological clue, yet it must be interpreted alongside the patient's fever trajectory, cough quality, and chest imaging. I evaluate your IgM level in conjunction with clinical signs to distinguish true acute infection from low-titer cross-reactivity. The objective is not merely to identify the pathogen but to deploy targeted therapy that restores respiratory function efficiently and safely."

— Dr. Ajay Singh, General Practitioner, DHA Registration ID: 36234132

⛔ Critical Safety Advisory & Exclusion Criteria

⚠️ Medication Advisory: Do not alter or discontinue any prescribed antibiotic or respiratory medication before or after this test without explicit direction from your treating physician. Premature cessation of therapy may lead to treatment failure or disease progression.

  • Home Collection Exclusion: Patients experiencing high-grade fever (>39.5°C) accompanied by severe dyspnea or oxygen desaturation require immediate emergency department assessment; mobile phlebotomy is not appropriate in this setting.
  • Pediatric Consent Requirement: For minors, this serological test requires in-person consent from a pediatrician or legal guardian in accordance with Federal Decree-Law No. 4 of 2016 on Medical Liability. Home collection for unaccompanied minors is strictly prohibited.
  • Emergency Red Flag: A strongly positive IgM titer in the presence of confusion, pleuritic chest pain, or hemoptysis constitutes a medical emergency. Proceed directly to the nearest hospital emergency department.

Patient FAQ & Clinical Guidance

1. What does a positive Mycoplasma pneumoniae IgM result indicate for my treatment plan?

A positive IgM result indicates an active or very recent primary infection with Mycoplasma pneumoniae, warranting prompt initiation of targeted antibiotic therapy. Your physician will use this serological evidence to prescribe a macrolide antibiotic such as azithromycin, avoiding beta-lactam agents that are ineffective against this intracellular pathogen. Clinical response should be re-evaluated within 48 to 72 hours to confirm therapeutic efficacy.

2. Is fasting or any special preparation required before the Mycoplasma IgM blood draw?

No fasting or special preparation is necessary. You may eat, drink, and take all routinely prescribed medications as normal before this serological test. The ELISA assay detects circulating IgM antibodies that remain stable irrespective of recent food intake, ensuring both your convenience and the diagnostic accuracy of the result.

3. Can a negative IgM with a positive IgG result reliably exclude current Mycoplasma infection for school or work clearance?

A negative IgM combined with a positive IgG pattern typically excludes an active, ongoing Mycoplasma pneumoniae infection and indicates past exposure with serological immunity. For formal clearance, your physician will correlate these serology results with your current symptom status and a normal chest auscultation to confidently certify that you are non-infectious and safe to return to school or work.

UAE Regulatory & Data Privacy Adherence

🔒 Your Data. Your Rights. Our Commitment.

All personal health information and serology results are processed and stored in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety protocols and patient consent procedures adhere strictly to Federal Decree-Law No. 4 of 2016 on Medical Liability. DNA Labs UAE maintains ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139) and operates under the regulatory oversight of the Dubai Health Authority (DHA).

Your serum specimen is handled exclusively by DHA-licensed phlebotomists and laboratory professionals. Results are delivered via encrypted, HIPAA-aligned channels. You retain the right to access, correct, or request deletion of your personal data at any time under PDPL.

Clinical & Logistical Metadata

Test Name Mycoplasma Pneumoniae IgM Serum Test
Price (AED) 450 AED
Turnaround Time Next-Day Report
Sample Type / Matrix Serum (peripheral venipuncture)
Methodology Used Quantitative ELISA (ISO 9001:2015)
ICD-10-CM Code J15.7
LOINC Code 23881-0
DHA Facility License & Laboratory Address DHA Facility License No. 1143 — Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians